Skip to main content
. 2022 Nov 30;8(12):1262. doi: 10.3390/jof8121262

Figure 1.

Figure 1

Proportion of positive responses to the different rationales for using Beta-D-Glucan (BDG) from a total of 18 positive answers. IC, invasive candidiasis; NICU, neonatal intensive care unit; PICU, paediatric intensive care unit; IFD, invasive fungal disease; AMS, antimicrobial stewardship.